2'574 companies found
Carobway GmbH
Bättwil · Since 2024
Carobway GmbH develops and commercializes bioactive and clean‑label food ingredients derived from the whole carob fruit. Its portfolio includes a natural low‑GI sweetener, prebiotic powders and ingredient solutions for food, dietary supplements and cosmetic applications, supported by an end‑to‑end, vertically integrated supply chain from cultivation to processing.
Cassiopee Applied Analytical Systems Sàrl
Carrouge Vd · Since 2017
The core activity of Cassiopee Applied Analytical Systems is the development and manufacture of analytical systems and solutions for chemical analysis, particularly in the field of chromatography and spectroscopy.
CDR-Life AG
Horgen · Since 2017
The company develops and commercializes new medicines, particularly T-cell activated cancer medicines, and provides services in the areas of research and development, clinical trials, pharmacology, toxicology and analytics.
CEBIS INTERNATIONAL SAGL
Lugano · Since 2016
The core activity of CEBIS is the conduct of clinical trials and the provision of regulatory services for the pharmaceutical industry, biotechnology companies, and manufacturers of medical devices. This includes, among other things: Conduct of clinical trials (Phase II-IV), regulatory support for market authorization, management of clinical trials, creation of regulatory documents (e.g. CTD for medicinal products), conduct of disease registries, and regulatory affairs and compliance services. CEBIS positions itself as a full-service provider for clinical research and regulatory services, offering its customers a comprehensive range of services to support their products from idea to market authorization.
CELL RECEPTOR SA
Geneva · Since 2015
CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.
cellvie AG
Zurich · Since 2020
The core activity of cellvie is the development of cell-based medicines, in particular by exploiting the therapeutic potential of mitochondria. The company focuses on the development of Therapeutic Mitochondrial Transplantation (TMT), a novel treatment approach aimed at improving cellular energy production and thereby treating various diseases and conditions such as ischemia-reperfusion injury, aging and others.
Centenara Labs AG
Baar · Since 2019
The core activity of Centenara Labs AG is the development and investment in therapies that combat age-related diseases such as cancer, muscle weakness, vision loss, and cognitive impairments. The company focuses on researching and developing medications that address the so-called "Hallmarks of Aging" to improve the health and well-being of older people and extend their lifespan.
Center for Space and Aviation
Dübendorf · Since 2024
The core activity of UZH Space Hub is research and development in the field of space and aeronautics, particularly in the areas of astrophysics, Earth observation, life sciences in space, and supercomputing. The company also operates a platform for start-ups and spin-offs in the field of space and aeronautics and provides infrastructure and networks for researchers and companies.
Cerefort GmbH
Fürigen · Since 2020
The core activity of Cerefort is the development of functional foods based on scientific findings that support mitochondrial integrity and function to promote cellular fitness and slow down the aging process.
Qnomx AG
Basel · Since 2022
Qnomx AG is an AI-powered platform that automates the interpretation of cancer genomic profiles. It analyzes tertiary NGS reports and produces concise, clinically actionable summaries for clinical laboratories, bioinformatics companies and oncology clinics, accepting reports via a web interface or API.
CHELONIA SA
Lugano · Since 2002
The core activity of Chelonia SA is to support academic spin-offs and start-ups in the development of market-ready products and services. This includes providing strategic consulting, facilitating partnerships, and supporting the acquisition of public and private funding, particularly within the framework of EU programs such as Horizon Europe. Additionally, Chelonia SA offers services such as innovation consulting, R&D acceleration, spin-off incubation, and venture support to promote the development of new technologies and products.
ChemAlive SA
Lausanne · Since 2014
ChemAlive SA provides automated cloud-based quantum chemistry services and contract research for chemical research. Its work includes quantum chemical calculations for reaction mechanism elucidation and optimization, kinetic modelling, molecular design, virtual screening and prediction of molecular and spectroscopic properties, together with software APIs and data access for integration into research workflows.
Chemoforma AG
Augst Bl · Since 1966
Chemoforma AG develops and manufactures natural complementary feed products for livestock and companion animals and supplies products for aquaculture. The company is GMP+ and ISO 9001 certified and markets product lines such as ASCOGEN®, VANNAGEN®, BIORACING® and ASCOSAN®.
ChondroNest SA
Conthey · Since 2015
ChondroNest SA develops a patented composition of modified biopolymers from the extracellular matrix designed to reconstruct cartilage. The technology is a surgeon-placeable, shapeable paste that solidifies under biocompatible conditions to reconstruct the ECM scaffold in vivo; the company is pursuing preclinical studies toward applications in hyaline cartilage repair.
CHoNova AG
Oberhasli · Since 2024
The core activity of ChoNova AG is the development and application of additive manufacturing (3D printing) in the food industry, particularly in the field of chocolate production. The company develops innovative solutions such as the DetachLog device and works on optimizing processes in food production.
CIPEL Distribution SA
Pfyn · Since 2017
CK-CARE AG
Davos Wolfgang · Since 2002
The core activity of CK-CARE is the research and development of therapies for rare diseases, particularly atopic dermatitis (neurodermatitis), through high-quality research in a scientific network in the field of allergology. The company focuses on collecting and evaluating data and samples in a biobank to enable a better understanding of complex diseases and develop innovative therapies and prevention strategies.
CleverCity GmbH
Wetzikon Zh · Since 2020
The core activity of CleverCity is the development and implementation of products and solutions in the Smart City and Smart Energy sectors, particularly in intelligent street lighting control and load management applications. The company offers customer-specific solutions, applications, and hardware and firmware developments, and has a network of specialists in the lighting industry.
Clinical Drug Development Consulting AG
Flüh · Since 2013
The core activity of Clinical Drug Development Consulting AG (Ltd) is the consulting and support of companies in the clinical development of drugs, particularly in the early stages of development (first-in-human studies and proof-of-concept studies). This also includes services such as clinical pharmacology studies, early patient studies, and clinical development (Phase I-IV). The company also offers interim executives such as Chief Medical Officer, Chief Safety Officer, and Chief Pharmacovigilance Officer.
CLINIQUE PODERM SARL
Carouge Ge · Since 2022
The core activity of PODERM is the development of products and methods for the treatment of foot and nail diseases.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register